Children’s National Hospital

Washington, DC, USA
Joined on

about this


Each year, the Brain Tumor Institute at Children’s National evaluates more than 100 new patients with brain tumors, and is recognized as a world leader in childhood brain tumor care and research. Children’s National has pioneered novel pediatric brain tumor therapies, including new molecularly-targeted therapies, vaccines, T-cell immunotherapies, and less invasive techniques. They are currently ranked #6 among children’s cancer hospitals by U.S News & World Report.

Children treated at Children’s National Hospital have access to the latest, most effective treatments for brain tumors, and are cared for by a multidisciplinary team of experts in both neurology and oncology, who are committed to saving lives and providing the best possible care for children with brain tumors.


Augustine Eze | Clinical Research Coordinator

meet the


Eugene Hwang.jpg

Scientific Committee

Eugene Hwang, MD

Eugene (Gene) Hwang, M.D., is part of the Children's National Hospital pediatric neuro-oncology team, focusing on treating children with brain tumors. Dr. Hwang has developed and led many novel early phase therapeutic clinical trials with a focus on immunotherapeutic trials, and he also leads trials


Scientific Committee

Robert Keating, MD

Robert Keating, M.D., is currently Professor and Chief of Neurosurgery at Children’s National Hospital. A graduate of Georgetown University Medical School, he completed a neurosurgery residency and fellowship in pediatric neurosurgery/craniofacial surgery at the Albert Einstein and Montefiore Medica


Scientific Committee

Miriam Bornhorst, MD

Brain tumors, Cancer genetics, Neurofibromatosis

Samuel Rivero-Hinojosa PhD.png

Samuel Rivero-Hinojosa, PhD

Samuel Rivero-Hinojosa, Ph.D., is a Staff Scientist at the Children’s National Research Institute focused on pediatric brain tumors. He is interested on integrative bioinformatics for Genomic and Proteomics to discover the functional biology and new treatment options for childhood brain tumors. He h


Site Coordinator

Augustine Eze, MS

My name is Augustine Eze and I have the privilege of serving as the interim Children’s Brain Tumor Network coordinator at Children’s National Hospital. I completed both my undergraduate degree in Biology, concentrating in Global Health, and my masters degree in Physiology and Biophysics at Georgetow

Scott Raskin, DO

Dr. Scott I. Raskin is a pediatrician in Washington, District of Columbia and is affiliated with Children's National Hospital. He received his medical degree from Western University College of Osteopathic Medicine of the Pacific and has been in practice between 3-5 years.


Scientific co-Chair

Roger Packer, MD

Dr. Packer has been heavily involved in clinical and applied basic science research. His clinical research has touched on various aspects of adult and child neurology and neuro-oncology, including adult and pediatric brain tumors, neurofibromatosis type 1, the neurologic aspects of childhood neurog